Every material Form 8-K CME filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CME Group reported third-quarter 2026 results on October 21, 2026, with revenue of $1.7 billion, up from $1.5 billion a year earlier, and diluted earnings per share of $2.89, up from $2.49. Adjusted diluted EPS was $3.02 versus $2.68 a year earlier, and the company returned nearly $1 billion to shareholders during the quarter.
Q3 2026 total revenues of $1,737.3 million versus $1,537.6 million in Q3 2025
Diluted EPS of $2.89 versus $2.49; adjusted diluted EPS of $3.02 versus $2.68
Average daily volume of 29.4 million contracts, a third-quarter record
Returned nearly $1 billion to shareholders: $465 million in dividends and $524 million in share repurchases
CME Group announced senior leadership changes in its finance and legal divisions. Jack Tobin becomes Deputy Chief Financial Officer on November 2, 2026, and Chief Financial Officer in March 2027, when Lynne Fitzpatrick becomes Chief Executive Officer. The changes also bring a new General Counsel, John Marchese, and a new Chief Accounting Officer, Matthew Render, but the filing gives no financial results or figures tied to these appointments.
Jack Tobin becomes Deputy Chief Financial Officer on November 2, 2026, and Chief Financial Officer in March 2027, when Lynne Fitzpatrick becomes Chief Executive Officer.
Matthew Render succeeds Tobin as Managing Director, Chief Accounting Officer effective November 2, 2026, after joining CME Group in August 2026.
John Marchese is promoted to General Counsel, succeeding Jonathan Marcus, who has served as General Counsel since 2022 and is stepping down later this month.
Tobin previously planned to retire effective October 30, 2026, but will now continue with the company.
CME Group reported second-quarter 2026 results for the quarter ended June 30, 2026. Total revenue rose to $1.7 billion from $1.69 billion a year earlier, and diluted earnings per share were $2.88 versus $2.81, but GAAP operating income fell to $1.1 billion from $1.13 billion.
Total revenue was $1,706.2 million, up from $1,692.0 million in Q2 2025; clearing and transaction fees were $1,352.5 million.
Diluted EPS was $2.88 versus $2.81; adjusted diluted EPS was $2.99 versus $2.96.
Operating income was $1,107.1 million versus $1,129.3 million; adjusted operating income was $1,185.0 million versus $1,200.8 million.
As of June 30, 2026, cash was $2.3 billion and debt was $3.4 billion; the company repurchased $695 million of its common shares and paid about $468 million in dividends in the quarter.
CME Group said Chairman and CEO Terry Duffy will become Executive Chairman, and President and CFO Lynne Fitzpatrick will succeed him as CEO. The change takes effect on the later of March 1, 2027 and the date the company files its 2026 Form 10-K. The company will also search for a new CFO to succeed Fitzpatrick.
Transition effective on the later of March 1, 2027 and the filing date of the 2026 Form 10-K; Board approved it June 16, 2026
Duffy serves as Executive Chairman from the Transition Date through December 31, 2027
Fitzpatrick's agreement sets a $1.2 million annual base salary, a bonus opportunity of 200% of salary and a long-term incentive opportunity of 700% of salary
Fitzpatrick's severance includes a lump sum of two times annual base salary and 18 months of Company-paid healthcare coverage
CME's clearing unit, Chicago Mercantile Exchange Inc., amended its 364-day secured credit facility, effective April 22, 2026, as Amendment No. 11. The facility provides temporary liquidity for clearing-related disruptions and is eligible to be increased to $10 billion. The filing describes it as a routine backstop for the clearing house and does not report a financial result or a change in shareholder economics.
Amendment No. 11 to the 364-day multi-currency credit facility effective April 22, 2026
Facility is $7 billion revolving secured credit, eligible to be increased to $10 billion
Bank of America, N.A. is Administrative Agent; Citibank, N.A. is Collateral Agent and Collateral Monitoring Agent
CME must remain in compliance with a consolidated tangible net worth test
CME Group reported first-quarter 2026 results on April 22, 2026, with revenue of $1.9 billion, up 14% from a year earlier, and net income of $1.2 billion. Diluted earnings per share were $3.18, compared with $2.62 in the first quarter of 2025, and adjusted diluted earnings per share were $3.36, compared with $2.80. The filing does not include updated full-year guidance.
Average daily volume reached 36.2 million contracts, up 22% from the first quarter of 2025.
Diluted EPS was $3.18 versus $2.62 a year earlier; adjusted diluted EPS was $3.36 versus $2.80.
Operating income was $1.3 billion, compared with $1.1 billion in the first quarter of 2025.
The company paid about $2.7 billion in dividends and repurchased $536 million of common shares in the quarter.
On February 4, 2026, CME Group reported fourth-quarter and full-year 2025 results, with full-year revenue of $6.5 billion and operating income of $4.2 billion. Full-year GAAP diluted earnings per share were $11.16, up from $9.67 in 2024, and the company said it was the fourth consecutive year of record annual revenue and adjusted earnings per share.
Fourth-quarter 2025 revenue was $1.6 billion, compared with $1.5 billion in the fourth quarter of 2024.
Fourth-quarter 2025 GAAP diluted EPS was $3.24 versus $2.40; adjusted diluted EPS was $2.77 versus $2.52.
Full-year 2025 adjusted diluted EPS was $11.20 versus $10.26 in 2024.
Record 2025 average daily volume of 28.1 million contracts; Q4 ADV was 27.4 million contracts, up 7% from Q4 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CME filing is on SEC EDGAR ↗. 8-K briefs of other companies →